Glutamine, MTOR and autophagy: a multiconnection relationship

40Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer cells metabolize glutamine mostly through glutaminolysis, a metabolic pathway that activates MTORC1. The AMPK-MTORC1 signaling axis is a key regulator of cell growth and proliferation. Our recent investigation identified that the connection between glutamine and AMPK is not restricted to glutaminolysis. Rather, we demonstrated the crucial role of ASNS (asparagine synthetase (glutamine-hydrolyzing)) and the GABA shunt for the metabolic control of the AMPK-MTORC1 axis during glutamine sufficiency. Our results elucidated a metabolic network by which glutamine metabolism regulates the MTORC1-macroautophagy/autophagy pathway through two independent branches involving glutaminolysis and ASNS-GABA shunt. Abbreviations: αKG: alpha-ketoglutarate; AMPK: AMP-activated protein kinase; ASNS: asparagine synthetase (glutamine-hydrolyzing); GLUD/GDH: glutamate dehydrogenase; GLS: glutaminase; GOT1: glutamic-oxaloacetic transaminase 1; MTORC1: mechanistic target of rapamycin kinase complex 1; TCA: tricarboxylic acid.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bodineau, C., Tomé, M., Murdoch, P. del S., & Durán, R. V. (2022). Glutamine, MTOR and autophagy: a multiconnection relationship. Autophagy, 18(11), 2749–2750. https://doi.org/10.1080/15548627.2022.2062875

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Professor / Associate Prof. 2

33%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

57%

Agricultural and Biological Sciences 1

14%

Medicine and Dentistry 1

14%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Save time finding and organizing research with Mendeley

Sign up for free